A302-057A-M
- Brand
- Bethyl Laboratories
- Application
- F
ICC-IF
IP
WB
- Storage Conditions
- 2 - 8° C
- Host
- Rabbit
- Conjugation
- Unconjugated
- Immunogen
- between 1221 and 1271
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09% Sodium Azide
- Reactivity
- Human
- Target
- BCR
- Shelf Life
- 1 year from date of receipt
- Antibody Type
- Polyclonal
- Alternate Names
- ALL, BCR/FGFR1 chimera protein, BCR1, breakpoint cluster region, breakpoint cluster region protein, CML, D22S11, D22S662, FGFR1/BCR chimera protein, PHL, renal carcinoma antigen NY-REN-26
- Format
- Whole IgG
- Presumed Reactivity
- Based on 100% sequence identity, this antibody is predicted to react with Mouse
- Product Type
- Primary Antibodies
- Product Sub Types
- Primary Antibodies
- UNSPSC
- 12352203
- Western Blot (WB)
- 1:2,000 - 1:10,000
- Immunoprecipitation (IP)
- 10 µg/mg lysate
- Immunocytochemistry-Immunofluoresence (ICC-IF)
- 1:500 - 1:2,000
- Flow Cytometry (F)
- 0.5 µg per 1 X 10^6 cells in a 150 µl volume
- Target Sentence
- BCR (breakpoint cluster region) was identified as part of a fusion protein that results from a reciprocal translocation with the ABL gene between chromosomes 22 and 9. The BCR-ABL fusion is the cause of chronic myeloid leukemia (CML). The BCR protein contains a C2 domain, a DBL-homology domain, a PH domain, and a Rho-GAP domain and functions as a GTPase-activating protein for RAC1 and CDC42.
- Product Link
- http://www.bethyl.com/product/A302-057A